NeurogesX CEO Anthony DiTonno to Retire by Year End (NGSX)

NeurogesX, Inc. NGSX, a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced that long time CEO Anthony DiTonno will retire by December 31, 2011. The Board of Directors has initiated a formal executive search for a Chief Executive Officer.